Stroke · 1996 · 80 citations · 41 references
MedicineMolecular GeneticsCardiovascular GeneticsHemostasisMedical GeneticsAnticoagulant TherapyCoagulation AbnormalitiesCoagulation Factor DeficienciesStrokeThromboembolic DiseaseThrombosisActivated Protein C ResistanceFactor V MutationMutationNatural Anticoagulant DeficiencyNatural Anticoagulant ProteinsPoint Mutation AnalysisPoint Mutation ScreeningProtein C Pathway Impairment
BACKGROUND AND PURPOSE: Resistance to activated protein C (APC), a natural plasma anticoagulant, is the most common identifiable risk factor for venous thromboembolic disease. One point mutation in coagulation factor V that renders it APC-resistant is found in >90% of APC-resistant venous thrombosis patients. To determine the prevalence of APC resistance and of this factor V mutation in stroke, we screened a group of ischemic stroke patients. METHODS: Hispanic ischemic stroke patients were screened using two different activated partial thromboplastin time-based assays. One assay using neat patient plasma determined APC resistance, and the other assay using patient plasma diluted into factor V-deficient plasma determined APC-resistant factor V, including the Arg506-->Gln mutation. Results were compared with those in 31 Hispanic control subjects of similar ages. RESULTS: Six of 63 (9.5%) stroke patients had APC resistance compared with none of 31 (0%) control subjects. No patient or control subject had APC-resistant factor V, ie, the factor V Arg506-->Gln mutation. CONCLUSIONS: In Hispanic patients with ischemic stroke, the incidence (approximately 10%) of APC resistance is not caused by the factor V Arg506-->Gln mutation. APC resistance not caused by this factor V mutation may be a risk factor for ischemic stroke in this population.
41
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations
Medicine, Hematology, Hemostasis +14
World distribution of factor V Leiden
David C. Rees, Michael J. Cox, J. B. Clegg · The Lancet · 1995 · 1.2K citations